Botanical species · safety record

Tribulus terrestris

The EFSA Compendium of Botanicals holds 16 constituent measurements and 9 adverse-effect records for Tribulus terrestris. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Tribulus terrestris L.

16Constituent measurements
9Safety records
8Cited sources
1,031Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1,031 licensed products naming Tribulus terrestris as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • Fresh
  • decoction
  • fluid

Source material stated

  • Aerial parts
  • Aerial parts (standardized extract)
  • Aerial parts extract
  • Fruit
  • Fruit (standardized extract)
  • Fruit Powder
  • Fruit and leaf
  • Fruit extract

What the records describe

Constituents measured

  • Harmalol2
  • Harmane alkaloids2
  • Calcium oxalate1
  • Carboline alkaloids1
  • Cyanide1
  • Harmol1
  • Moupinamide1
  • N-p-coumaroyltyramine1
  • Nitrate1
  • Nitrites1

Plant parts

  • Unspecified18
  • Leaves5
  • Fruit unspecified1

Preparations

  • Solvent extraction13

Effect types

  • Digestive2
  • Hepatotoxicity2
  • Neurotoxicity2
  • Hemopoietic1
  • Nephrotoxicity1
  • Pulmonary and cardiac1

Target tissues

  • Cardiovascular2
  • Urogenital: kidneys2
  • haematological2
  • Digestive1
  • Digestive: pancreas1
  • Liver1
  • Muscle, skeletal1
  • Neurologic1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
MoupinamideUnspecifiedSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
N-p-coumaroyltyramineUnspecifiedSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
PhenylpropanoidsUnspecifiedSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
Calcium oxalateLeavesSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
Carboline alkaloidsUnspecifiedSolvent extractionChromatographic testsNo resolvable identifier
CyanideLeaves14.4 ppmColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
HarmalolUnspecifiedSolvent extraction≥ 414 Nanogram/gramChromatographic testsNo resolvable identifier
HarmalolUnspecifiedSolvent extraction≤ 486 Nanogram/gramChromatographic testsNo resolvable identifier
Harmane alkaloidsUnspecifiedSolvent extraction≤ 143 Nanogram/gramChromatographic testsNo resolvable identifier
Harmane alkaloidsUnspecifiedSolvent extraction≥ 75.2 Nanogram/gramChromatographic testsNo resolvable identifier
HarmolUnspecifiedSolvent extraction≤ 453 Nanogram/gramChromatographic testsNo resolvable identifier
NitrateLeaves15.28 Milligram/gramColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
NitritesLeaves9.71 Milligram/gramColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
NorharmaneUnspecifiedSolvent extraction96.2 Nanogram/gramChromatographic testsNo resolvable identifier
OxalatesLeaves0.14 PercentColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
SaponinsFruit unspecifiedSolvent extractionUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestive: pancreasUnspecifiedSolvent extractionIn vitroResolve DOI
DigestiveDigestiveUnspecifiedGoat (as animal)SubchronicResolve DOI
HemopoieticCardiovascular / haematologicalUnspecifiedGoat (as animal)SubchronicResolve DOI
HepatotoxicityLiverUnspecifiedHuman (as organism)Case reportResolve DOI
HepatotoxicityUrogenital: kidneysUnspecifiedGoat (as animal)SubchronicResolve DOI
NephrotoxicityUrogenital: kidneysUnspecifiedHuman (as organism)Case reportResolve DOI
NeurotoxicityNeurologicUnspecifiedHuman (as organism)Case reportResolve DOI
NeurotoxicityMuscle, skeletalSheep (as animal)OtherResolve DOI
Pulmonary and cardiacCardiovascular / haematologicalUnspecifiedGoat (as animal)SubchronicResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Hemalatha, S., Hari, R. Acute and subacute toxicity studies of the saponin rich butanol extracts of tribulus terrestris fruits in wistar rats. International journal of pharmaceutical sciences review and research, 2014, vol. 27, no. 2, p. 307-313.
  2. Song, Yeong Hun., Kim, Dae Wook., Curtis-Long, Marcus J., Park, Chanin., Son, Minky., Kim, Jeong Yoon., Yuk, Heung Joo., Lee, Keun Woo., Park, Ki Hun. Cinnamic acid amides from Tribulus terrestris displaying uncompetitive alpha-glucosidase inhibition . European journal of medicinal chemistry, 2016, vol. 114, p. 201-208. DOI
  3. Aslani, MR., Movassaghi, AR., Mohri, M., Ebrahim-Pour, V., Mohebi, AN. Experimental Tribulus terrestris poisoning in goats. Small ruminant research, 2004, vol. 51, no. 3, p. 261-267. DOI
  4. Talasaz, Azita Hajhossein., Abbasi, Mohammad-Reza., Abkhiz, Saeed., Dashti-Khavidaki, Simin. Tribulus terrestris-induced severe nephrotoxicity in a young healthy male . Nephrology dialysis transplantation, 2010, vol. 25, no. 11, p. 3792-3793. DOI
  5. Bourke, CA. Abnormal turning behaviour, GABAergic inhibition and the degeneration of astrocytes in ovine Tribulus terrestris motor neuron disease . Australian veterinary journal, 2006, vol. 84, no. 1-2, p. 53-58. DOI
  6. Tsuchiya, Hironori., Hayashi, Hideaki., Sato, Masaru., Shimizu, Hiroshi., Iinuma, Munekazu. Quantitative analysis of all types of beta-carboline alkaloids in medicinal plants and dried edible plants by high performance liquid chromatography with selective fluorometric detection. Phytochemical analysis, 1999, vol. 10, no. 5, p. 247-253.
  7. Tutuncu Konyar, Sevil., Ozturk, Necla., Dane, Feruzan. Occurrence, types and distribution of calcium oxalate crystals in leaves and stems of some species of poisonous plants. Botanical studies, 2014, vol. 55, no. 1, p. 1-9.
  8. Abatan, M. O., Arowolo, R. O., Olurunsogo, O. O. Phytochemical analysis of some commonly occurring poisonous plants in Nigerian pastures . Tropical veterinarian, 1997, vol. 15, no. 1-2, p. 49-54.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue